Merck To Pay Nearly $1B To Settle Vioxx Marketing Claims
Drug giant Merck Sharp & Dohme Corp. has agreed to pay $950 million to settle criminal charges and civil claims for illegally marketing the painkiller Vioxx for off-label uses and allegedly...To view the full article, register now.
Already a subscriber? Click here to view full article